KPMG @ J.P Morgan Healthcare Conference 2020
KPMG @ J.P Morgan Healthcare Conference 2020
EVENT

Join us

KPMG at the 38th Annual J.P. Morgan Healthcare Conference

Various locations | San Francisco, CA



  • Overview
  • Session 1
  • Session 2
  • Session 3

Overview

Join KPMG at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, CA, January 13-16, 2020. We will be hosting a series of premier events where you will learn from our top strategy, legal, and financial partners and engage with luminaries across the life sciences and healthcare industries about the future of innovation and dealmaking worldwide.

You won't want to miss this opportunity to get forward-thinking perspectives and insights on key life sciences and healthcare topics. Please register for these sessions as seating is limited!

We look forward to seeing you at the J.P. Morgan Healthcare Conference!

__________________________________________

  • Session 1: Healthcare industry leader panel
    Monday, January 13, 2020 at 4:00 pm PT
    Register now!
  • Session 2: Health Care Investment Outlook 2020 - Briefing Sessions
    - Monday January 13, 2020 at 1:00 pm PT  
    - Tuesday, January 14, 2020 at 8:00 am PT  or 2:00 pm PT
    All Briefing Sessions full! 
    If you would like to be put on the waiting list, please click here. We will contact you if space becomes available.
  • Session 3: Goodwin + KPMG @ JPMorgan Symposium 
    Wednesday, January 15, 2020 at 8:30 am - 6:00 pm PT
    Registration closed! 
    If you would like to be put on the waiting list, please click here. We will contact you if space becomes available.

See session tabs above for descriptions, agendas, and registration details. 

Session 1

Healthcare industry leader panel

When: Monday, January 13, 4:00 pm PT

Where: KPMG offices, 55 2nd Street, San Francisco, CA

REGISTER

The healthcare industry is increasingly under pressure to demonstrate the value of care being delivered, while also aiming to improve patient experience and empowering them to make informed decisions. The emphasis on controlling costs and maintaining high quality necessitates developing innovative approaches and technologies that can meet patient needs and demands across the care continuum. This distinguished panel of business leaders will discuss how their organizations are navigating the evolving healthcare market through unique partnerships, innovations, and investments that move the healthcare system to a value-driven industry, all in the face of ongoing regulatory and legislative reforms.  

Panelists include:

  • Vishal Agrawal M.D., Chief Strategy & Corporate Development Officer, Humana
  • Monika Brown, Sr. Vice President of M&A, McKesson  
  • David Causby, President & CEO, Kindred at Home 
  • Scott Whyte, Chief Strategy Officer, ClearDATA.

__________________________________________

Session 2

Health Care Investment Outlook 2020

When:
- Monday, January 13, 1:00 pm PT 
- Tuesday, January 14, 8:00 am PT or 2:00 pm PT

All Briefing Sessions full! 
If you would like to be put on the waiting list, please click here. We will contact you if space becomes available.

Where: Sir Francis Drake Hotel, 450 Powell Street, San Francisco, CA

KPMG will unveil the results from our annual healthcare and life sciences investment landscape survey, and provide insights on factors driving market changes, policy and regulatory disruptors, and investor considerations for 2020. The KPMG authors of the report will be discussing its findings and implications with senior leaders from Leavitt Partners, including Governor Mike Leavitt, former Secretary of U.S. Department of Human Health and Services (HHS).

We hope you can join us for this exciting and timely discussion on insights from our survey about what to expect from the healthcare and life sciences investment landscape for 2020. 

__________________________________________

Session 3

Learn with Us: Goodwin + KPMG @ JPMorgan Symposium at the St. Regis Hotel

When: Wednesday, January 15, 8:30 am - 6:15 pm PT

Where: St. Regis, 125 3rd Street, San Francisco, CA

Registration closed! If you would like to be put on the waiting list, please click here. We will contact you if space becomes available.

 

Learn with us at this special symposium co-hosted by Goodwin + KPMG on Wednesday, January 15, 8:30 am - 6:15 pm.

The symposium will provide the latest insights and perspectives from healthcare and life sciences industry professionals and will address key topics including:

  • Disconnected to Connected: New Frontiers in Digital Diagnostics & Medtech
  • Europe Unleashed: 2020 Vision for EU Growth Stage Venture Funding and Maximizing Returns through Structured M&As
  • Startups Break Through: Knowing the Best IPO Strategy
  • Trends in Biopharma: Evaluating and Partnering New Technologies and Emerging Business Models
  • Mergers and Acquisitions: The Brave New World of Antitrust in Life Sciences M&A

__________________________________________

Goodwin + KPMG @ JPMorgan Symposium 
Full Agenda

8:30 am – 8:45 am  Welcome Remarks

 

Burst 1 | New Frontiers in Digital Diagnostics & Medtech

8:50 am – 9:05 am  Current State of the Healthcare Sector & Regulations

9:10 am – 9:55 am  New Frontiers in MedTech Space on the Global Stage: What are the Challenges in IP, Regulatory and Commercial

  • Kristin Ciriello Pothier, Global Healthcare and Life Sciences Strategy Leader, KPMG (Moderator)
  • Nicholas Mitrokostas, Partner, Goodwin
  • Stefan Scherer, Global Head of Experimental Medicine, GlaxoSmithKline (GSK)
  • Joseph Zaccaria, Client Growth Director, TrialSpark
  • Reena L. Pande, MD MSc, Chief Medical Officer, AbleTo

10:00 am – 10:45 am  Panel: Issues Facing Therapeutic Companies Using ML and AI in Drug Discovery Methods

  • Danielle Lauzon, Partner, Goodwin (Moderator)
  • David Berry, General Partner, Flagship; CEO, Integral
  • Dan Housman, Co-founder, CTO Graticule, Co-founder Courage Therapeutics

 

Keynote Speech

10:55 am – 11:40 am  Keynote Speaker - Stéphane Bancel, CEO, Moderna

11:40 am – 12:10 pm  Lunch Break

 

Burst 2 | Europe Unleashed

12:10 pm – 12:40 pm The Evolving Landscape for Growth-Stage Venture Funding in Europe

  • Sophie McGrath, Partner, Goodwin (Moderator)
  • Francesco De Rubertis, Co-Founder and Partner, Medicxi
  • Dirk Kersten, General Partner, Forbion

12:45 pm – 1:15 pm Maximizing Returns through Structured M&As

  • Graham Defries, Partner, Goodwin (Moderator)
  • Erik van den Berg, CEO, AM-Pharma
  • Geert-Jan Mulder, Co-Founder and Managing Partner, Forbion
  • Maarten de Jong, Managing Director, Moelis & Company

 

Burst 3 | Knowing the Best IPO Strategy

1:20 pm – 1:40 pm  2020 Vision for the IPO Market

  • Amit Sinha, Managing Director, Investment Banking Division, Goldman Sachs

1:40 pm – 2:10 pm  Traditional US IPO Route: “The Two Minute Drill” to Complete a Successful IPO in the First Six Months of the Year

  • Janet Lehman, National Leader, VC Life Sciences, KPMG (Moderator)
  • Tom Koncsics, Partner, KPMG
  • Michael Bison, Partner, Goodwin
  • Jack Cassel, Vice President, Nasdaq
  • Amit Sinha, Managing Director, Investment Banking Division, Goldman Sachs

2:15 pm – 2:45 pm  Hong Kong IPO: Seizing Opportunities in a New Emerging Market for Biotech IPOs

  • Wendy Pan, Partner, Goodwin Hong Kong (Moderator)
  • Irene Chu, Partner, Head of New Economy and Life Sciences, Hong Kong, KPMG China
  • Michael Chan, Head of International Issuer Business, Hong Kong Exchanges and Clearing Limited (HKEX)
  • Bin Li, Founder and Chief Investment Officer, Lake Bleu Capital 

2:50 pm – 3:20 pm  Alternatives to U.S. IPO: Reverse Mergers and Direct Listings

  • Deepa Rich, Partner, Goodwin (Moderator)
  • Gerry Schemidt, Partner, Audit, KPMG
  • Mitchell H. Gold, Executive Chairman & CEO, Alpine Immune Sciences
  • David Snyder, Chief Financial Officer, Exicure

3:20 pm – 3:30 pm  Coffee & Networking

 

Burst 4 | Trends in Biopharma

3:30 pm – 4:10 pm  Evaluating and Partnering New Technologies and Emerging Business Models

  • Kingsley Taft, Partner, Goodwin (Moderator)
  • Jeff Stoll, Principal, National Life Sciences Strategy Leader, KPMG
  • Nicholas Pullen, Ph.D., Executive Director of Inflammation & Immunology Integrative Sciences, Bristol-Myers Squibb

 

Burst 5 | Mergers and Acquisitions

4:15 pm – 5:15 pm  The Brave New World of Antitrust in Life Sciences M&A

 

5:15 pm – 6:15 pm  Cocktails & Networking

--------------------------------------------------------

Event co-hosted by:

 

KPMG Speakers

  • Janet M. Lehman, Partner, Audit
    National Venture Capital Life Sciences Leader

  • Kristin C. Pothier, Principal, Advisory
    Global Healthcare and Life Sciences Strategy Leader

  • Jeff Stoll, Principal, Advisory
    National Life Sciences Strategy Leader

  • Tom Koncsics, Partner, Audit

  • Gerry Schemidt, Partner, Audit

  • Irene Chu, Partner
    Head of New Economy and Life Sciences, Hong Kong

  • Carole Streicher, National Lead Partner Healthcare & Life Sciences Deal Advisory

  • S. Lawrence Kocot, Principal
    National Leader, Center for Healthcare Regulatory Insight

  • Brett Glover, Partner
    Healthcare & Life Sciences Deal Advisory

  • Andrew Stephenson, Partner
    Healthcare & Life Sciences Deal Advisory